// App-Quantinova.ai

3399 : A Real World Longitudinal Analysis of Anemia Treatment Prescriptions in Non-Dialysis-Dependent Chronic Kidney Disease Patients, a CKDopps Study

Researchers

Presenter

  • Marcelo Barreto Lopes

Principal Investigators

  • Charlotte Tu

  • Jarcy Zee

  • Murilo H. Guedes

  • Ronald L. Pisoni

  • Bruce M. Robinson

  • Katarina Hedman

  • Glen James

  • James A. Sloand

  • Ziad Massy

  • Antonio A. Lopes

  • Helmut Reichel

  • Sandra Wchter

  • Michelle M. Wong

  • Roberto Pecoits-Filho

Medical Centers

  • Arbor Research Collaborative for Health, Ann Arbor, MI

  • Pontificia Universidade Catolica do Parana (PUC-PR), Curitiba, Brazil

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca, Gaithersburg, MD

  • Universite Paris 11, Villejuif, France

  • Universidade Federal da Bahia, Salvador, Brazil

  • Nephrological Center, Villingen Schwenningen, Germany

  • Vifor Pharma, Glattbrugg, Switzerland

  • University of British Columbia Faculty of Medicine, Vancouver, BC, Canada

Locations

  • United States

  • Brazil

  • Sweden

  • United Kingdom

  • France

  • Germany

  • Switzerland

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Non-dialysis-dependent chronic kidney disease

  • Anemia

Biomarkers

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A